Drug profile · INN
bromocriptine mesylate
BROMOCRIPTINE MESYLATE
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
bromocriptine mesylate (BROMOCRIPTINE MESYLATE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN bromocriptine mesylate
Brand BROMOCRIPTINE MESYLATE
Route ORAL
Formulation CAPSULE
Frequently asked questions
What is bromocriptine mesylate?
bromocriptine mesylate (BROMOCRIPTINE MESYLATE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for bromocriptine mesylate?
BROMOCRIPTINE MESYLATE is a marketed brand name for bromocriptine mesylate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of bromocriptine mesylate?
bromocriptine mesylate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.